Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Construction of HFV Vector-Mediated GAD Gene and Its Application

Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes.

Efficient Therapeutic Gene Expression in Cultured Rat Hippocampal Neurons Mediated by Human Foamy Virus Vectors: A Potential for the Treatment of Neurological Diseases

Amplification of Human GAD67 Gene and Construction of Its Eukaryotic Expression Vector Pegfpc2-Gad67

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury.

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

Establishment of a Stable Glutamate Decarboxylase (gad) Expressing Cell-Line by Transfection

[Construction of Eukaryotic Expression Vector for Human Glial Derived Neurotrophic Factor and Its Expression in Spinal Cord Tissue of SD Rat].

Constraction of Replication—defective Hum an Foamy Virus Vector Directing Expression of Foreign Genes

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease

The Experimental Study of Construction of Recombinant Plasmid Pegfp-Gdnf and Its Expression in Eukaryotic Cell

Construction and Identification of Recombinant Adenoviral Vector Carrying Homeobox Gax Gene

Study on the Transfection of Constrction Replication-Defective Virus Vector Helper Plasmid P△gp to HIC Cell

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a

Construction and Identification of Eukaryotic Expression Vector Containing GAD65 Fragment and IL-10 Gene

Construction of the recombinant adenovirus vectors containing human glutathione peroxidase gene

The Construction and Package of Herpes Simplex Virus Type I Amplicon Vector with CGRP Gene Transferred

[Construction of Lentiviral Vectors Encoding GDNF and GDNF Expression in Human Neural Stem Cells].

Construction of Pcdna3.1(+) Glial Cell Line-Derived Neurotrophic Factor(gdnf) Vector and Its Expression in Eukaryotic Cells